Clinical Trial Update: Cetuximab for Unresectable Cutaneous Squamous Cell Carcinoma - A National Retrospective Study

View source ↗

Summary

A national retrospective study investigating cetuximab for unresectable cutaneous squamous cell carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Skin

Drugs mentioned

• Cetuximab (cetuximab)

Snippet

Sponsor: Centre Antoine Lacassagne | Conditions: Squamous Cell Cutaneous Carcinoma of the Skin | Status: COMPLETED